Business Description
Kadimastem Ltd
ISIN : IL0011284614
Description
Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.28 | |||||
| Equity-to-Asset | -1.52 | |||||
| Debt-to-Equity | -0.9 | |||||
| Debt-to-EBITDA | -1.27 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 44.3 | |||||
| 3-Year EPS without NRI Growth Rate | 42 | |||||
| 3-Year FCF Growth Rate | 43.5 | |||||
| 3-Year Book Growth Rate | 36.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | -1.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.33 | |||||
| Quick Ratio | 0.33 | |||||
| Cash Ratio | 0.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -28.2 | |||||
| Shareholder Yield % | -0.39 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -124.6 | |||||
| ROIC % | -72.41 | |||||
| ROC (Joel Greenblatt) % | -381.2 | |||||
| ROCE % | -1135.16 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -6.96 | |||||
| EV-to-EBITDA | -9.52 | |||||
| EV-to-FCF | -8 | |||||
| Earnings Yield (Greenblatt) % | -14.37 | |||||
| FCF Yield % | -13.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:KMSTF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kadimastem Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.365 | ||
| Beta | -0.21 | ||
| Volatility % | 1.48 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 6.404 | ||
| 12-1 Month Momentum % | -1.48 | ||
| 52-Week Range ($) | 6.404 - 6.5 | ||
| Shares Outstanding (Mil) | 4.19 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kadimastem Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kadimastem Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kadimastem Ltd Frequently Asked Questions
What is Kadimastem Ltd(KMSTF)'s stock price today?
The current price of KMSTF is $6.40. The 52 week high of KMSTF is $6.50 and 52 week low is $6.40.
When is next earnings date of Kadimastem Ltd(KMSTF)?
The next earnings date of Kadimastem Ltd(KMSTF) is .
Does Kadimastem Ltd(KMSTF) pay dividends? If so, how much?
Kadimastem Ltd(KMSTF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers